Source:http://linkedlifedata.com/resource/pubmed/id/12053227
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2002-6-7
|
| pubmed:abstractText |
Metallothioneins (MTs) are zinc-binding proteins whose overexpression may lead to sequestration of zinc ions and consequently to functional inactivation of the p53 tumor suppressor gene. The aim of the study was to investigate the potential role of MTs in the carcinogenesis of ulcerative colitis (UC) as well as possible effects on p53 function. The monoclonal antibodies E9 (anti-MT), DO-7, and 1801 (anti-p53) and the polyclonal antibody CM-1 (anti-p53) were used to stain formalin-fixed, paraffin-embedded colon specimens obtained from 14 patients with UC-associated colorectal carcinoma (CAC), 13 with high-grade dysplasia (HGD), 10 with low-grade dysplasia (LGD), and 30 with UC without dysplasia or carcinoma. Statistical significance (p <0.05) was assessed using Fisher's exact test. Positive MT staining (> 20% of tumor, dysplastic, or epithelial cells) was found in most UC and LGD but in only a small percentage of HGD and CAC (p <0.01 for CAC vs. UC and LGD vs. HGD). Positive p53 immunoreactivity was observed predominantly in HGD and CAC but not in LGD and UC (p <0.01 for CAC vs. UC and HGD vs. LGD). In histologically normal tissue neighboring CAC, significant MT expression was found in six of seven specimens with simultaneous lack of p53 expression. MT overexpression may represent an important early step in the development of CAC independent of p53 expression and should be investigated in the long term as an independent cancer risk factor in UC.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0364-2313
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
26
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
726-31
|
| pubmed:dateRevised |
2005-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:12053227-Adenocarcinoma,
pubmed-meshheading:12053227-Adult,
pubmed-meshheading:12053227-Aged,
pubmed-meshheading:12053227-Biological Markers,
pubmed-meshheading:12053227-Cell Transformation, Neoplastic,
pubmed-meshheading:12053227-Colitis, Ulcerative,
pubmed-meshheading:12053227-Colorectal Neoplasms,
pubmed-meshheading:12053227-Humans,
pubmed-meshheading:12053227-Immunohistochemistry,
pubmed-meshheading:12053227-Metallothionein,
pubmed-meshheading:12053227-Middle Aged,
pubmed-meshheading:12053227-Precancerous Conditions,
pubmed-meshheading:12053227-Risk Factors,
pubmed-meshheading:12053227-Tumor Suppressor Protein p53
|
| pubmed:year |
2002
|
| pubmed:articleTitle |
Metallothionein: early marker in the carcinogenesis of ulcerative colitis-associated colorectal carcinoma.
|
| pubmed:affiliation |
Department of General Surgery, University of Muenster, Waldeyerstrasse 1, D-48149 Muenster, Germany. bruewer@uni-muenster.de
|
| pubmed:publicationType |
Journal Article
|